文献速递心外重症与机械循环支持

循环死亡供心移植扩展至高危受体

Expanding Use of Donation After Circulatory Death Heart Transplantation to Higher Acuity Recipients.
PubMed 文献 · Ann Thorac Surg · 2025-10-28

该研究基于UNOS数据库2019年12月至2023年12月的12352例成人心脏移植(DCD 1114例,DBD 11238例),分析DCD受体特征的时间趋势并按移植前等待名单状态分层比较1年生存。结果显示DCD移植占比从3.6%升至15.2%,高危受体比例增加,但各等待名单状态下DCD与DBD的1年生存均无显著差异。

要点

  • DCD心脏移植占比从2019/2020年3.6%增至2023年15.2%。
  • Status 1和2受体比例从17.6%升至52.6%,机械循环支持使用增加。
  • 按等待名单状态分层,DCD与DBD的1年生存无显著差异。

核心结论

  • DCD心脏在高危受体中使用显著扩展,且1年生存与DBD移植相当。
  • 经适当选择,可鼓励在高危受体中更积极使用DCD供心。

研究设计与样本

  • 回顾性队列研究,基于UNOS数据库2019年12月1日至2023年12月31日数据。
  • 纳入12352例首次孤立成人心脏移植,其中DCD 1114例,DBD 11238例。
  • 按移植前等待名单状态分层,比较DCD与DBD的1年移植后生存。

主要发现

  • DCD心脏移植占比从2019年12月/2020年的3.6%升至2023年的15.2%(P < .001)。
  • Status 1和2受体比例从17.6%升至52.6%,移植前机械循环支持使用从13.9%升至20.2%(均P < .05)。
  • 校正后各等待名单状态1年生存无显著差异:status 1和2 HR 1.12(95%CI 0.84-1.51),status 3 HR 1.01(95%CI 0.63-1.61),status 4 HR 0.82(95%CI 0.51-1.31),status 6 HR 0.88(95%CI 0.43-1.80)。

临床怎么用

  • 在高危受体中可考虑使用DCD供心,但需适当选择。
  • DCD与DBD移植后1年生存相当,支持扩展DCD应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Donation after circulatory death (DCD) hearts were initially used more often in medically stable recipients, reflecting both caution for use in higher risk patients and greater availability to lower acuity candidates. We examined temporal trends in DCD recipient characteristics and compared outcomes of DCD with donation after brain death (DBD) transplants, stratified by pretransplant recipient waitlist status. METHODS: From the United Network for Organ Sharing database (December 1, 2019-December 31, 2023), we identified 12,352 first-time, isolated adult heart transplants (DCD, 1114; DBD, 11,238). Temporal trends in DCD recipient characteristics were analyzed. The primary end point was 1-year posttransplant survival compared between DCD and DBD cohorts after stratifying by pretransplant waitlist status. December 2019 data were combined with 2020. RESULTS: DCD heart transplantation accounted for 3.6% of all heart transplants in December 2019/2020 and 15.2% in 2023 (P < .001). The proportion of DCD recipients with status 1 and 2 listing increased from 17.6% in December 2019/2020 to 52.6% in 2023, with more frequent use of pretransplant mechanical circulatory support (13.9% to 20.2%; both P < .05). After adjustment, DCD and DBD cohorts had similar 1-year survival irrespective of pretransplant waitlist status (status 1and 2: hazard ratio [HR], 1.12 [95% CI, 0.84-1.51]; status 3: HR, 1.01 [95% CI, 0.63-1.61]; status 4: HR, 0.82 [95% CI, 0.51-1.31]; status 6: HR ,0.88 [95% CI, 0.43-1.80]). CONCLUSIONS: The use of DCD hearts has expanded significantly in higher acuity recipients. One-year survival in these recipients remains equivalent to DBD transplants. With appropriate selection, more aggressive use of DCD donor hearts may be encouraged in higher acuity recipients.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Razavi AA, Chen Q, Tam DY, et al. Expanding Use of Donation After Circulatory Death Heart Transplantation to Higher Acuity Recipients. Ann Thorac Surg. 2025. PMID: 41167576. doi:10.1016/j.athoracsur.2025.10.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。